Ario Pharma
Cambridge
About Ario Pharma
Ario Pharma ltd focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1 inhibitor, in two Phase 2 clinical trials that will read out in 2014. The company is managed by a highly experienced development team and supported by world-renowned KOLs in respiratory disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.1M
- Funding stage: Seed
- Last round: Seed (Dec 2013)
- Website: ariopharma.com
- Phone: (+44) 1223 493922
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ario-pharma-3065007 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.